Frazier Life Sciences XI, L.P. bought $10M of ATTO stock

Frazier Life Sciences XI, L.P., 10% owner of Attovia Therapeutics, Inc. (ATTO), bought 588,235 shares of ATTO stock worth $10M, per an SEC Form 4 filed Aug 6, 2026.

It was an open-market purchase.

The trade was reported on Aug 6, 2026.

ATTO has moved -25.8% since the trade date, from $20.38 to $15.13 (Nov 13, 2026 close).